REVIVA PHARMACEUTICALS HOLDINGS, INC. Logo

REVIVA PHARMACEUTICALS HOLDINGS, INC.

Clinical-stage biopharma developing therapeutics for CNS, respiratory & metabolic diseases.

RVPH | US

Overview

Corporate Details

ISIN(s):
VGG8708A1167 (+1 more)
LEI:
Country:
United States of America
Address:
10080 N WOLFE ROAD, 95014 CUPERTINO

Description

Reviva Pharmaceuticals Holdings, Inc. is a clinical-stage biopharmaceutical company that discovers and develops next-generation therapeutics for diseases with significant unmet medical needs. The company's primary focus is on central nervous system (CNS), respiratory, and metabolic diseases. Its lead drug candidate, brilaroxazine (RP5063), is in clinical development for multiple neuropsychiatric indications, including schizophrenia, bipolar disorder, major depressive disorder, behavioral and psychotic symptoms in Alzheimer's disease, Parkinson's disease psychosis, and attention deficit hyperactivity disorder (ADHD). Reviva utilizes a chemical genomics-driven technology platform to develop medicines with the goal of achieving better safety and efficacy profiles for improved patient outcomes.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all REVIVA PHARMACEUTICALS HOLDINGS, INC. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for REVIVA PHARMACEUTICALS HOLDINGS, INC.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for REVIVA PHARMACEUTICALS HOLDINGS, INC. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

BioSenic SA Logo
Develops therapies for autoimmune diseases, inflammation, and bone disorders.
Belgium
BIOS
BIOTECH Logo
A biotechnology group offering preclinical services, intein development, and licensing.
Spain
BST
Biovica International B Logo
Develops blood-based biomarker assays for cancer therapy monitoring.
Sweden
BIOVIC
Bonus BioGroup Ltd. Logo
A clinical-stage biotech firm developing cell therapy and tissue engineering products.
Israel
BONS
BRAIN Biotech AG Logo
Develops enzymes and microorganisms for the food, chemical, and life sciences sectors.
Germany
BNN
BriaCell Therapeutics Corp. Logo
Clinical-stage immuno-oncology company developing cellular immunotherapies for cancer.
United States of America
BCTX
BSF ENTERPRISE PLC Logo
Develops cell-based solutions for cultivated meat, leather, and corneal repair.
United Kingdom
BSFA
BullFrog AI Holdings, Inc. Logo
A technology company applying AI and machine learning to drug development.
United States of America
BFRG
Burning Rock Biotech Ltd Logo
A global diagnostics company specializing in precision oncology using NGS technology.
United States of America
BNR
Cabaletta Bio, Inc. Logo
Develops engineered T cell therapies for B cell-mediated autoimmune diseases.
United States of America
CABA

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.